Victoria T Guenther Lcsw Llc - Medicare Mental Health Clinic in Sarasota, FL

Victoria T Guenther Lcsw Llc is a medicare enrolled mental health clinic (Social Worker - Clinical) in Sarasota, Florida. The current practice location for Victoria T Guenther Lcsw Llc is 1991 Hyde Park St, Sarasota, Florida. For appointments, you can reach them via phone at (214) 326-3674. The mailing address for Victoria T Guenther Lcsw Llc is 923 Citrus Ave, Sarasota, Florida and phone number is (941) 955-2868.

Victoria T Guenther Lcsw Llc is licensed to practice in Florida (license number SW14248). The clinic also participates in the medicare program and its NPI number is 1194214478. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (214) 326-3674.

Contact Information

Victoria T Guenther Lcsw Llc
1991 Hyde Park St
Sarasota
FL 34239-3612
(214) 326-3674
Not Available

Mental Health Clinic Profile

Full NameVictoria T Guenther Lcsw Llc
SpecialitySocial Worker
Location1991 Hyde Park St, Sarasota, Florida
Authorized Official Name and PositionVictoria L Turner-guenther (SOLE MBR)
Authorized Official Contact2143263674
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Victoria T Guenther Lcsw Llc
923 Citrus Ave
Sarasota
FL 34236-8413

Ph: (941) 955-2868
Victoria T Guenther Lcsw Llc
1991 Hyde Park St
Sarasota
FL 34239-3612

Ph: (214) 326-3674

NPI Details:

NPI Number1194214478
Provider Enumeration Date05/02/2018
Last Update Date05/02/2018

Medicare PECOS Information:

Medicare PECOS PAC ID7719242999
Medicare Enrollment IDO20180518001025

News Archive

Spanish tool measures infant pain rapidly and simply

It turns out to be difficult to find out exactly how much a child who cannot yet speak suffers after a surgical operation. Researchers at the University Hospital of La Paz, in Madrid, have validated the 'Llanto' scale, the first, and only, tool in Spanish which measures infant pain rapidly and simply.

Inhibitors of cellular enzymes could be developed for SARS treatment

Researchers from the University of Pennsylvania School of Medicine have found that inhibitors of an enzyme called cathepsin L prevent the SARS (severe acute respiratory syndrome) virus from entering target cells. SARS is caused by an emergent coronavirus. There is no effective treatment at this time.

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy.

DaVita HealthCare announces results for third quarter 2013

DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2013. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2013 was $211.0 million and $605.3 million, or $0.98 and $2.82 per share, respectively, excluding a loss contingency reserve. In addition, adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the nine months ended September 30, 2013 excluded a contingent earn-out obligation adjustment. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2013 including these items was $136.6 million and $407.9 million, or $0.64 per share and $1.90 per share, respectively.

Genetic selection of target stem cell populations

Human embryonic stem cells can be genetically manipulated to help select out desirable cell types, according to a University of Nottingham study published online in Molecular Therapy.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Victoria T Guenther Lcsw Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1194214478NPI-NPPES
SW14248OtherFLLCSW

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical SW14248 (Florida)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Victoria T Guenther Lcsw Llc acts as a billing entity for following providers:
Provider NameVictoria L Guenther
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1912410036
PECOS PAC ID: 3173888252
Enrollment ID: I20180625000880

News Archive

Spanish tool measures infant pain rapidly and simply

It turns out to be difficult to find out exactly how much a child who cannot yet speak suffers after a surgical operation. Researchers at the University Hospital of La Paz, in Madrid, have validated the 'Llanto' scale, the first, and only, tool in Spanish which measures infant pain rapidly and simply.

Inhibitors of cellular enzymes could be developed for SARS treatment

Researchers from the University of Pennsylvania School of Medicine have found that inhibitors of an enzyme called cathepsin L prevent the SARS (severe acute respiratory syndrome) virus from entering target cells. SARS is caused by an emergent coronavirus. There is no effective treatment at this time.

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy.

DaVita HealthCare announces results for third quarter 2013

DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2013. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2013 was $211.0 million and $605.3 million, or $0.98 and $2.82 per share, respectively, excluding a loss contingency reserve. In addition, adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the nine months ended September 30, 2013 excluded a contingent earn-out obligation adjustment. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2013 including these items was $136.6 million and $407.9 million, or $0.64 per share and $1.90 per share, respectively.

Genetic selection of target stem cell populations

Human embryonic stem cells can be genetically manipulated to help select out desirable cell types, according to a University of Nottingham study published online in Molecular Therapy.

Read more Medical News

› Verified 4 days ago

News Archive

Spanish tool measures infant pain rapidly and simply

It turns out to be difficult to find out exactly how much a child who cannot yet speak suffers after a surgical operation. Researchers at the University Hospital of La Paz, in Madrid, have validated the 'Llanto' scale, the first, and only, tool in Spanish which measures infant pain rapidly and simply.

Inhibitors of cellular enzymes could be developed for SARS treatment

Researchers from the University of Pennsylvania School of Medicine have found that inhibitors of an enzyme called cathepsin L prevent the SARS (severe acute respiratory syndrome) virus from entering target cells. SARS is caused by an emergent coronavirus. There is no effective treatment at this time.

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy.

DaVita HealthCare announces results for third quarter 2013

DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2013. Adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2013 was $211.0 million and $605.3 million, or $0.98 and $2.82 per share, respectively, excluding a loss contingency reserve. In addition, adjusted income from continuing operations attributable to DaVita HealthCare Partners Inc. for the nine months ended September 30, 2013 excluded a contingent earn-out obligation adjustment. Income from continuing operations attributable to DaVita HealthCare Partners Inc. for the three and nine months ended September 30, 2013 including these items was $136.6 million and $407.9 million, or $0.64 per share and $1.90 per share, respectively.

Genetic selection of target stem cell populations

Human embryonic stem cells can be genetically manipulated to help select out desirable cell types, according to a University of Nottingham study published online in Molecular Therapy.

Read more News

› Verified 4 days ago

Social Worker in Sarasota, FL

Bluestone Psychiatry, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5664 Bee Ridge Rd Ste 203, Sarasota, FL 34233
Phone: 877-422-9355    Fax: 877-422-9355
Suncoast Therapy, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5224 Station Way, Sarasota, FL 34233
Phone: 941-485-0121    Fax: 941-485-0519
Robert K Winegar Psy D
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1991 Hyde Park St, Sarasota, FL 34239
Phone: 941-953-4313    Fax: 941-954-8631
Marilyn Pearlman Pa
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3293 Fruitville Rd Unit 103, Sarasota, FL 34237
Phone: 941-366-4411    Fax: 941-366-4641
Dmr Counseling Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2881 Clark Rd Ste 11, Sarasota, FL 34231
Phone: 941-315-5999    
Centerpointe Counseling And Recovery Of Sarasota
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 5632 Bee Ridge Rd, Unit101, Sarasota, FL 34233
Phone: 941-488-4811    Fax: 941-488-4899
Jacque Ruch, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 3205 Southgate Cir Ste 19, Sarasota, FL 34239
Phone: 815-243-8332    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.